Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.841
-0.021 (-2.48%)
Nov 21, 2024, 3:47 PM EST - Market open
Carisma Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 26.88 | 77.61 | 24.19 | 28.55 | 51.79 |
Short-Term Investments | 1.25 | - | 27.8 | - | - |
Cash & Short-Term Investments | 28.13 | 77.61 | 52 | 28.55 | 51.79 |
Cash Growth | -70.12% | 49.25% | 82.12% | -44.87% | - |
Prepaid Expenses | 0.5 | 2.87 | 2.6 | 1.24 | 1.28 |
Total Current Assets | 34.14 | 80.47 | 54.59 | 29.79 | 53.07 |
Property, Plant & Equipment | 7.71 | 8.94 | 13.45 | 5.66 | 5.19 |
Long-Term Deferred Charges | 0.21 | 0.15 | 4.11 | - | - |
Other Long-Term Assets | - | - | - | - | 0.21 |
Total Assets | 42.06 | 89.55 | 72.15 | 35.45 | 58.46 |
Accounts Payable | 1.73 | 3.93 | 1.73 | 2.32 | 3.29 |
Accrued Expenses | 4.54 | 7.66 | 10.36 | 4.47 | 1.57 |
Current Portion of Leases | 2.46 | 1.94 | 4.6 | 0.9 | 0.81 |
Current Unearned Revenue | 0.68 | 1.41 | 2.46 | - | - |
Other Current Liabilities | 1.15 | 0.97 | 0.52 | - | - |
Total Current Liabilities | 10.56 | 15.91 | 19.67 | 7.69 | 5.68 |
Long-Term Debt | - | - | 33.72 | - | - |
Long-Term Leases | 0.86 | 1.19 | 1.85 | 1.73 | 2.63 |
Long-Term Unearned Revenue | 41.25 | 45 | 45 | - | - |
Other Long-Term Liabilities | 0.52 | 0.93 | 6.78 | - | - |
Total Liabilities | 53.18 | 63.02 | 107.02 | 9.43 | 8.31 |
Common Stock | 0.04 | 0.04 | 0 | - | - |
Additional Paid-In Capital | 276.78 | 271.59 | 1.2 | 0.82 | 0.34 |
Retained Earnings | -287.94 | -245.1 | -158.22 | -97 | -56.21 |
Comprehensive Income & Other | - | - | -0.04 | - | - |
Total Common Equity | -11.13 | 26.53 | -157.07 | -96.18 | -55.87 |
Minority Interest | - | - | 14.4 | 14.4 | 14.4 |
Shareholders' Equity | -11.13 | 26.53 | -34.86 | 26.02 | 50.15 |
Total Liabilities & Equity | 42.06 | 89.55 | 72.15 | 35.45 | 58.46 |
Total Debt | 3.32 | 3.12 | 40.16 | 2.63 | 3.45 |
Net Cash (Debt) | 24.81 | 74.48 | 11.83 | 25.92 | 48.34 |
Net Cash Growth | -72.85% | 529.50% | -54.35% | -46.39% | - |
Net Cash Per Share | 0.60 | 2.22 | 5.56 | 23.91 | 45.46 |
Filing Date Shares Outstanding | 41.75 | 41.54 | 1.17 | 11.09 | 1.06 |
Total Common Shares Outstanding | 41.75 | 40.61 | 1.17 | 1.08 | 1.06 |
Working Capital | 23.58 | 64.56 | 34.92 | 22.1 | 47.39 |
Book Value Per Share | -0.27 | 0.65 | -134.52 | -88.72 | -52.55 |
Tangible Book Value | -11.13 | 26.53 | -157.07 | -96.18 | -55.87 |
Tangible Book Value Per Share | -0.27 | 0.65 | -134.52 | -88.72 | -52.55 |
Machinery | - | 8.76 | 7.63 | 3.96 | 2.09 |
Construction In Progress | - | 0.01 | 0.01 | 0.01 | - |
Leasehold Improvements | - | 0.34 | 0.34 | 0.32 | 0.32 |
Source: S&P Capital IQ. Standard template. Financial Sources.